Literature for peptidase C01.032: cathepsin L

(References are filtered for relevance to Target. To remove the filter click here. See explanation.)

2017
1. Xu,S., Zhang,H., Yang,X., Qian,Y. and Xiao,Q.
   Inhibition of cathepsin L alleviates the microglia-mediated neuroinflammatory responses through caspase-8 and NF-kappaB pathways
   Neurobiol Aging62, 159-167. PubMed  Europe PubMed DOI  T
2016
2. Garsen,M., Rops,A.L., Dijkman,H., Willemsen,B., van Kuppevelt,T.H., Russel,F.G., Rabelink,T.J., Berden,J.H., Reinheckel,T. and van der Vlag,J.
   Cathepsin L is crucial for the development of early experimental diabetic nephropathy
   Kidney Int90, 1012-1022. PubMed  Europe PubMed DOI  T
2010
3. Frizler,M., Stirnberg,M., Sisay,M.T. and Gutschow,M.
   Development of nitrile-based peptidic inhibitors of cysteine cathepsins
   Curr Top Med Chem10, 294-322. PubMed  Europe PubMed DOI  T  I